
44 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Leung, Hematologist in Stanford, CA?
Dr. Lawrence Leung, MD is a Hematologist, who primarily practices in Stanford, CA with 2 additional practice locations. He has been practicing for over 44 years and is board certified. Dr. Leung completed his residency at Ny & Presby Hp-Cornell Campus, Hematology-Internal Medicine; Ny & Presby Hp-Cornell Campus, Internal Medicine. Dr. Leung is fluent in English and Chinese, and is currently seeing new patients. Dr. Leung’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Leung’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Leung?
Dr. Lawrence Leung, MD is a highly-rated, board-certified Hematologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Leung empowers patients to confidently navigate their health journey, specializing in Bleeding/Coagulation Disorders, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Leung is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Leung go to medical school and complete their residency?
Fellowship: New York Hospital
Residency: Ny & Presby Hp-Cornell Campus, Hematology-Internal Medicine; Ny & Presby Hp-Cornell Campus, Internal Medicine | New York Hospital
Medical School: Columbia Univ Coll of Physicians And Surgeons, New York Ny
Is Dr. Leung board certified as a Hematologist?
Yes, Dr. Lawrence Leung, MD is board certified by the American Board of Internal Medicine , American Board of Internal Medicine since 1980, American Board of Internal Medicine since 1978
What languages does Dr. Leung speak?
Dr. Leung and their clinical team can communicate with patients in the following languages:
Chinese
English
What conditions does a Hematologist like Dr. Leung typically treat?
As a Hematologist, Dr. Leung diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Leung. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Antiphospholipid Syndrome
- Bleeding Disorder
- Antiphospholipid syndrome
- APS
- Hughes syndrome
- Sticky blood syndrome
ICD-10 Codes:
- D6861: Antiphospholipid syndrome
Also known as:
- Pulmonary Embolism
- Blood clot in lung
- Lung embolism
- PE
ICD-10 Codes:
- I2699: Other pulmonary embolism without acute cor pulmonale
Also known as:
- Long-Term Blood Thinner Use
- Blood Thinners
- Chronic anticoagulant therapy
- Ongoing blood thinner treatment
- Anticoagulant medication use
ICD-10 Codes:
- Z7901: Long term (current) use of anticoagulants
Also known as:
- Myelodysplastic Syndrome
- Myelodysplastic Syndromes
- Myelodysplastic Syndromes Treatment (PDQ®)
- MDS
- Preleukemia
- Bone marrow failure disorder
ICD-10 Codes:
- D469: Myelodysplastic syndrome, unspecified
What procedures does a Hematologist like Dr. Leung typically perform?
As a Hematologist, Dr. Leung performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Leung. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Blood Transfusion
- Blood Transfusion and Donation
- Blood product transfusion
- Red blood cell transfusion
- Plasma transfusion
CPT Codes:
- 36430: Transfusion, blood or blood components
Also known as:
- Excimer Laser Treatment for Psoriasis (Small Area)
- Laser Psoriasis Treatment
- UVB Laser for Psoriasis
- Targeted Phototherapy for Psoriasis
CPT Codes:
- 96920: Excimer laser treatment for psoriasis; total area less than 250 sq cm
Does Dr. Leung accept my insurance?
Dr. Leung accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Leung accept in Stanford, CA?
Dr. Leung in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Santa Cruz County
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Leung's office located?
Recognitions
Publications
Open aortic valve replacement in a patient with Glanzmann's thrombasthenia
, 2014
Targeting complement component 5a promotes vascular integrity and limits airway remodeling.
, 2013
Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignt Glial Tumors
, 2013
Microfluidic impedance cytometer for platelet alysis
, 2013
Chemerin158K Protein Is the Domint Chemerin Isoform in Synovial
, 2011
Proteolytic Cleavage of Chemerin Protein Is Necessary for Activation to the Active Form, Chem157S
, 2011
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
, 2011
Enhanced Abdomil Aortic Aneurysm Formation in Thrombin-Activatable Procarboxypeptidase B
, 2010
What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?
, 2010
Thrombospondin Type I Domain Containing 7A
, 2010
Heparin-induced thrombosis without thrombocytopenia
, 2010
Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N
, 2009
Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites
, 2008
Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin
, 2007
Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery
, 2004
Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation
, 2003
Thrombin activation of factor XI on activated platelets requires the interaction of factor XI
, 2003
An extensive interaction interface between thrombin
, 2001
Thrombin interacts with thrombomodulin, protein C
, 1999
SELECTION OF A SUPPRESSOR MUTATION THAT RESTORES AFFINITY OF AN OLIGONUCLEOTIDE INHIBITOR FOR
, 1995
FUNCTIOL MAPPING OF THE SURFACE RESIDUES OF HUMAN THROMBIN
, 1995
Conversion of thrombin into an anticoagulant by protein engineering
, 1995
Open aortic valve replacement in a patient with Glanzmann's thrombasthenia
, 2014
Targeting complement component 5a promotes vascular integrity and limits airway remodeling.
, 2013
Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors
, 2013
Microfluidic impedance cytometer for platelet analysis
, 2013
Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial
, 2011
Proteolytic Cleavage of Chemerin Protein Is Necessary for Activation to the Active Form, Chem157S
, 2011
Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
, 2011
Enhanced Abdominal Aortic Aneurysm Formation in Thrombin-Activatable Procarboxypeptidase B
, 2010
What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse?
, 2010
Thrombospondin Type I Domain Containing 7A
, 2010
Heparin-induced thrombosis without thrombocytopenia
, 2010
Thrombin-Activatable Carboxypeptidase B Cleavage of Osteopontin Regulates Neutrophil Survival
, 2009
Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N
, 2009
Regulation of tissue inflammation by thrombi n-activatable carboxypeptidase B (or TAFI)
, 2008
Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites
, 2008
Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin
, 2007
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo
, 2007
Antiangiogenic antithrombin induces global changes
, 2006
Perioperative evaluation of bleeding diathesis.
, 2006
Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery
, 2004
Molecular cloning of nonsecreted endothelial cell-derived lipase isoforms
, 2004
Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation
, 2003
Thrombin activation of factor XI on activated platelets requires the interaction of factor XI
, 2003
Structural requirements for the activation of human factor VIII by thrombin
, 2002
Identification of critical residues on thrombin mediating its interaction with fibrin
, 2001
An extensive interaction interface between thrombin
, 2001
Thrombin interacts with thrombomodulin, protein C
, 1999
Strategies for development of novel antithrombotics
, 1997
Modulation of thrombin's procoagulant and anticoagulant properties
, 1997
SELECTION OF A SUPPRESSOR MUTATION THAT RESTORES AFFINITY OF AN OLIGONUCLEOTIDE INHIBITOR FOR
, 1995
FUNCTIONAL MAPPING OF THE SURFACE RESIDUES OF HUMAN THROMBIN
, 1995
Conversion of thrombin into an anticoagulant by protein engineering
, 1995